Recurrent Thyroid Cancer Completed Phase 2 Trials for Romidepsin (DB06176)

Also known as: Thyroid cancer recurrent

IndicationStatusPhase
DBCOND0028815 (Recurrent Thyroid Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00098813Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive IodineTreatment